UCB Pharma S.A.
8 products tracked · names used in filings: UCB Pharma S.A.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Lacosamide Pain UCB Pharma lacosamide | Application withdrawn | |
| 🇪🇺 | Zilbrysq zilucoplan | Authorised | 2023-12-01 |
| 🇪🇺 | Bimzelx bimekizumab | Authorised | 2021-08-20 |
| 🇪🇺 | Fintepla fenfluramine | Authorised | 2020-12-18 |
| 🇪🇺 | Evenity romosozumab | Authorised | 2019-12-09 |
| 🇪🇺 | Lacosamide UCB lacosamide | Authorised | 2019-08-26 |
| 🇪🇺 | Leganto rotigotine | Withdrawn | 2011-06-16 |
| 🇪🇺 | Neupro rotigotine | Authorised | 2006-02-15 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.